Records 1 - 4
| Homozygous FCGR3A-158V alleles predispose to late onset neutropenia after CHOP-R for diffuse large B-cell lymphoma.
Internal medicine journal 2012 Oct 42 (10): 1113-9.
Keane C, Nourse J P, Crooks P, Nguyen-Van D, Mutsando H, Mollee P, Lea R A, Gandhi M
| Identification of patients with indolent B cell lymphoma sensitive to rituximab monotherapy.
Annals of hematology 2012 May 91 (5): 715-21.
Cornec Divi, Tempescul Adrian, Querellou Solène, Hutin Pascal, Pers Jacques-Olivier, Jamin Christophe, Bendaoud Boutahar, Berthou Christian, Renaudineau Yves, Youinou Pier
| Homozygous A polymorphism of the complement C1qA276 correlates with prolonged overall survival in patients with diffuse large B cell lymphoma treated with R-CHOP.
Journal of hematology & oncology 2012 5 (1): 51.
Jin Xuan, Ding Huirong, Ding Ning, Fu Zhiying, Song Yuqin, Zhu J
| A polymorphism in the complement component C1qA correlates with prolonged response following rituximab therapy of follicular lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Oct 14 (20): 6697-703.
Racila Emilian, Link Brian K, Weng Wen-Kai, Witzig Thomas E, Ansell Stephen, Maurer Matthew J, Huang Jian, Dahle Christopher, Halwani Ahmad, Levy Ronald, Weiner George